Provided by Tiger Trade Technology Pte. Ltd.

Phio Pharmaceuticals

1.18
-0.0300-2.48%
Pre-market: 1.09-0.0900-7.63%05:09 EDT
Volume:138.32K
Turnover:166.11K
Market Cap:13.71M
PE:-0.88
High:1.24
Open:1.24
Low:1.17
Close:1.21
52wk High:4.19
52wk Low:0.8127
Shares:11.62M
Float Shares:11.55M
Volume Ratio:0.56
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3423
EPS(LYR):-1.4535
ROE:-113.71%
ROA:-65.77%
PB:1.09
PE(LYR):-0.81

Loading ...

Dec 23, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 10, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 13, 2020

Major Issues Report

8-K - Current report
Aug 12, 2020

Major Issues Report

8-K - Current report
Aug 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 15, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 09, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
May 29, 2020

Correspondence

CORRESP [Cover] - Correspondence
May 28, 2020

Correspondence

CORRESP [Cover] - Correspondence
May 28, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2020

Major Issues Report

8-K - Current report
May 12, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Apr 09, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Apr 08, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Apr 02, 2020

Major Issues Report

Current report, items 1.01, 3.02, and 9.01
Mar 26, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 12, 2020

Major Issues Report

Current report, items 8.01 and 9.01